Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine in acute ischemic stroke
NCT02767999Phase 4Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Feb 2017
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemic stroke comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Intracerebral connectivity in the motor network at 90 days. Started Feb 2017; status: completed.
02
Drugs
fluoxetine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02767999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767999.